News
PMCPA News
Press releases appear below, filter by date.
All four companies have brought discredit upon, and reduced confidence in, the pharmaceutical industry.
Astellas UK and Gedeon Richter (UK) Ltd have brought discredit upon, and reduced confidence in, the pharmaceutical industry. Astellas UK has been publicly reprimanded and Gedeon Richter required to issue a corrective statement.
Astellas UK and Astellas Europe have brought discredit upon, and reduced confidence in, the pharmaceutical industry, in addition both have been publicly reprimanded. Pfizer Ltd, Novartis Pharmaceuticals UK Ltd and Tor Generics Ltd have brought discredit upon, and reduced confidence in, the pharmaceutical industry.
PMCPA ANNUAL REPORT SHOWS A BUSY YEAR, WITH MORE COMPLAINTS IN 2016 THAN IN THE PREVIOUS TWO YEARS.
Chiesi has been publicly reprimanded for providing inaccurate information to the PMCPA during the course of a complaint about a leave piece and again during the course of a subsequent audit and is the subject of advertisements in the medical, pharmaceutical and nursing press.
Galderma UK Ltd and Merck Serono have each breached Clause 2 of the ABPI Code of Practice and are the subject of advertisements in the medical, pharmaceutical and nursing press.
The ABPI and NHS England have issued a joint letter setting out the ambition to increase consent rates as quickly as possible for publication of payments to individuals on Disclosure UK. The letter, published on 22 December 2017 and signed by ABPI CEO Mike Thompson and NHSE National Director Ian Dodge, is now available on the ABPI website.
Both companies have brought discredit upon, and reduced confidence in, the pharmaceutical industry. In addition, PharmaMar has been publicly reprimanded and required to issue a corrective statement.
Proposals to amend the Code agreed at ABPI General Meeting on 20 November.
Proposals to amend the ABPI Code of Practice for the Pharmaceutical Industry and the PMCPA Constitution and Procedure were agreed at the Half Yearly General Meeting of the ABPI on 20 November 2014.
Servier Laboratories Ltd has breached Clause 2 of the ABPI Code of Practice and is the subject of advertisements in the medical, pharmaceutical and nursing press.
The PMCPA e-learning module for health professionals has been updated to reflect the 2014 Code of Practice.